High Content Screening Products Sales Market 2017 - 2022: Thermo Fisher Scientific, Molecular Devices, GE Healthcare, PerkinElmer Inc., Becton, Dickinson and Company
The global high content screening market will likely rise at a CAGR of 8.0% from 2017 to 2022 to become worth US$1.23 bn by 2022.
View full press release